Literature DB >> 7718903

Evaluation of CD38 as target for immunotherapy in multiple myeloma.

W C Vooijs, H J Schuurman, E J Bast, G C de Gast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7718903

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Current drug therapy for multiple myeloma.

Authors:  Y W Huang; A Hamilton; O J Arnuk; P Chaftari; R Chemaly
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 2.  Immunotherapies targeting CD38 in Multiple Myeloma.

Authors:  Djordje Atanackovic; Mary Steinbach; Sabarinath Venniyil Radhakrishnan; Tim Luetkens
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

3.  Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.

Authors:  Michael S van der Veer; Michel de Weers; Berris van Kessel; Joost M Bakker; Shulamiet Wittebol; Paul W H I Parren; Henk M Lokhorst; Tuna Mutis
Journal:  Haematologica       Date:  2010-11-25       Impact factor: 9.941

4.  Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display.

Authors:  Steffen Krohn; Ammelie Svea Boje; Carina Lynn Gehlert; Sebastian Lutz; Nikos Darzentas; Henrik Knecht; Dietrich Herrmann; Monika Brüggemann; Axel J Scheidig; Katja Weisel; Martin Gramatzki; Matthias Peipp; Katja Klausz
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.

Authors:  Damian J Green; Nural N Orgun; Jon C Jones; Mark D Hylarides; John M Pagel; Donald K Hamlin; D S Wilbur; Yukang Lin; Darrell R Fisher; Aimee L Kenoyer; Shani L Frayo; Ajay K Gopal; Johnnie J Orozco; Theodore A Gooley; Brent L Wood; William I Bensinger; Oliver W Press
Journal:  Cancer Res       Date:  2013-12-26       Impact factor: 12.701

Review 6.  A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.

Authors:  Faroogh Marofi; Heshu Sulaiman Rahman; Muhammad Harun Achmad; Klunko Nataliya Sergeevna; Wanich Suksatan; Walid Kamal Abdelbasset; Maria Vladimirovna Mikhailova; Navid Shomali; Mahboubeh Yazdanifar; Ali Hassanzadeh; Majid Ahmadi; Roza Motavalli; Yashwant Pathak; Sepideh Izadi; Mostafa Jarahian
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.